Search Results - PHARMACOLOGY OF DRUGS AFFECTING THE ENDOCRINE

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Comparative Pharmacological and Pharmaceutical Perspectives on Antidiabetic Therapies in Humans, Dogs, and Cats by Iljin Kim, Jang-Hyuk Yun

    Published in Pharmaceutics (2025-08-01)
    “…<b>Background/Objectives:</b> Diabetes mellitus (DM) is an increasingly prevalent endocrine disorder affecting humans and companion animals. …”
    Get full text
    Article
  5. 5

    Metabolic and Endocrine Insights in Donkeys by Francisco J. Mendoza, Ramiro E. Toribio, Alejandro Perez-Ecija

    Published in Animals (2024-02-01)
    “…Equine treatment protocols apply to donkeys, although pharmacological studies for most drugs, except pergolide, are lacking.…”
    Get full text
    Article
  6. 6
  7. 7

    A review of the effects of pharmaceutical pollutants on humans and aquatic ecosystem by Jaya Vinny Eapen, Sweety Thomas, Shelmi Antony, Paul George, Jayesh Antony

    Published in Exploration of Drug Science (2024-08-01)
    “…This research aimed to examine studies investigating the occurrence of antibiotics, endocrine disruptors, and other pharmaceutical products in water, sediments, and organisms within aquatic ecosystems. …”
    Get full text
    Article
  8. 8

    Pharmacological properties and therapeutic potential of berberine: a comprehensive review by Ke-Qin Fan, Ke-Qin Fan, Liangming Zhang, Fangyu Song, Fangyu Song, Yue-Hui Zhang, Tong Chen, Xiang Cheng, Ning Su, Yan Zou, Ting Yu, Futing Tan, Wenhao Xu, Zijun Yan, Zijun Yan

    Published in Frontiers in Pharmacology (2025-08-01)
    “…In recent decades, the pharmacological properties of botanical drugs have been investigated with increasing depth, offering novel insights into their potential for enhancing healthcare. …”
    Get full text
    Article
  9. 9

    Pharmacological methods for weight reduction and their connection with the human gut microbiota by Venelin Dimitrov Denchev, Teodora Svetoslavova Handjieva-Darlenska

    Published in Pharmacia (2023-12-01)
    “…During the last decade, significant advancements have been made in regard to treatment of many endocrine and metabolic conditions, using pharmacological means, and some of these novel medications have proven to be an effective therapy for obesity. …”
    Get full text
    Article
  10. 10
  11. 11

    Animal experiments and network pharmacology to explore the anti-inflammatory mechanism of dapagliflozin in the treatment of polycystic ovary syndrome by Yong Liu, He Bai, Huilin Guan, Chunhua Wang, Xueqing Song, Zihao Yong, Xiaomeng Guo, Luxin Li, Zhen Zhang

    Published in Gynecological Endocrinology (2025-12-01)
    “…Pathological changes in the ovaries were examined by H&E staining, changes in ovarian tissue cell apoptosis were identified using TdT-mediated dUTP Nick-End Labeling (TUNEL) staining, and changes in inflammation-related factors were detected using immunohistochemistry and Western blotting analysis. Network pharmacology was used to predict the inflammatory targets and pathways affected by dapagliflozin in treating PCOS, and the potential interactions between dapagliflozin and inflammation-related target proteins were evaluated through molecular docking.Results Our results demonstrated that dapagliflozin treatment significantly improved PCOS symptoms, recovered ovarian morphology and physiological functions, and reduced the apoptosis of ovarian cells after drug intervention. …”
    Get full text
    Article
  12. 12

    Integrated bioinformatics and network pharmacology to explore the therapeutic target and molecular mechanisms of Bailing capsule on polycystic ovary syndrome by Hao-ru Guan, Bo Li, Ze-hua Zhang, Han-song Wu, Xing-lishang He, Ying-jie Dong, Jie Su, Gui-yuan Lv, Su-hong Chen

    Published in BMC Complementary Medicine and Therapies (2023-12-01)
    “…This study demonstrated that BL exerted anti-PCOS effects via PIK3CA, ESR1, AKT, PPARG, and IRS1 targets affecting PI3K-Akt signaling pathways. Discussion This research clarified the multicomponent, multitarget, and multichannel action of BL and provided a theoretical reference for further investigations on its pharmacological basis and molecular mechanisms against PCOS.…”
    Get full text
    Article
  13. 13
  14. 14
  15. 15
  16. 16

    Female Gender as a Risk Factor for the Development of Drug-Induced Diseases by D. A. Sychev, O. D. Ostroumova, A. P. Pereverzev, A. I. Kochetkov, T. M. Ostroumova, M. V. Klepikova, E. Yu. Ebzeeva

    “…The aim of the study was to analyse and systematise data on the factors responsible for increased risk of drug-induced diseases in women. It was demonstrated that the increased risk of complications in women following the use of certain pharmacological classes of drugs is associated with a combination of factors that affect pharmacokinetics and pharmacodynamics. …”
    Get full text
    Article
  17. 17

    The Role of Pharmacists in Identifying and Preventing Drug-Related Problems in PCOS Management by Hristina Lebanova, Vesselina Yanachkova, Svetoslav Stoev

    Published in Pharmacy (2025-07-01)
    “…Polycystic ovary syndrome (PCOS) is an endocrine disorder prevalent in women of reproductive age, often requiring complex pharmacological management. …”
    Get full text
    Article
  18. 18
  19. 19
  20. 20

Search Tools: